Isomorphic Labs, an artificial intelligence drug discovery startup founded by former Google DeepMind chief Demis Hassabis, has raised a $5 billion Series C, the company said on Tuesday.
Isomorphic's round comes three-and-a-half months after Hassabis stepped back as CEO of DeepMind, Google's AI lab, which he co-founded before the Big Tech giant acquired it in 2014.
The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz, with investment from Alphabet, Google's parent. The fresh funds will help fund the design and development of new medicines using AI.
Drug discovery startups have seen record funding poured into them by investors in 2026 as companies look to capitalize on advances in AI. OpenAI and Anthropic have also been investing in tools to develop new medicines using the technology.
Hassabis has been CEO of Isomorphic Labs since the startup spun out of DeepMind in 2021.